Why Boston Scientific (BSX) shares are plunging today
Why Boston Scientific (BSX) shares are plunging today Shares of Boston Scientific (BSX) fell 8% after the company reported its third-quarter 2026 financial results, showing a 1.5% growth in net sales and efforts to restore operations following a cybersecurity incident. The company posted GAAP net income attributable to common stockholders of $582 million, or $0.40 per share, and adjusted earnings per share reaching $073 vs S&P analysts’ estimates of $00.72. However, the company's outlook for the full-year 2026 was overshadowed by a weaker near-term outlook, leading to a significant sell-off in the shares. Boston Scientific shares have dropped 55.7% since the beginning of the year and are now trading 60.1% below their 52-week high of $104.98 from November 2025.
公開済み : 5時間前 沿って の Business Health Finance
Shares of medical device company Boston Scientific (NYSE: BSX) fell 8% in the morning session after the company reported third-quarter 2026 financial results showing net sales growth of 1.5 percent an... [3059 symbols]
